The Hyderabad-based drugmaker said consolidated net profit rose to Rs 361 crore (Rs 3.61 billion) for the fiscal first quarter ended June, from Rs 336 crore (Rs 3.36 billion) a year earlier.
Revenue rose 12 per cent to Rs 2840 crore (Rs 28.4 billion).
Analysts, on an average, had forecast net profit at Rs 429 crore (Rs 4.29 billion) on net sales of Rs 3116 crore (Rs 31.16 billion).
Valued at nearly $6.6 billion, shares in Dr Reddy's Laboratories extended losses to more than 3 per cent after the Mumbai markets closed down about 1 per cent.
UPA endorses Telangana creation
Forbes' HIGHEST PAID actressses in Hollywood
Banks unlikely to up lending rates as loan demand is weak
BSE: Top losers and gainers
Won't take action against errant cops, govt to HC on FB row